Incidence of dyspnea and hyperventilation syndrome after COVID-19

W. MADI (Gabes, Tunisia), S. Mejdoub Fehri (Gabes, Tunisia), R. Sellami (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), H. Kwas (Gabes, Tunisia)

Source: International Congress 2022 – Miscellaneous: biomarkers for the management of chronic lung diseases

Session: Miscellaneous: biomarkers for the management of chronic lung diseases
Session type: Thematic Poster
Number: 234

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. MADI (Gabes, Tunisia), S. Mejdoub Fehri (Gabes, Tunisia), R. Sellami (Gabes, Tunisia), A. Eleuch (Gabes, Tunisia), R. Ammar (Gabes, Tunisia), I. Ketata (Gabes, Tunisia), H. Kwas (Gabes, Tunisia). Incidence of dyspnea and hyperventilation syndrome after COVID-19. 234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.